https://www.pharmaceuticalprocessingworld.com/difficult-transmembrane-protein-targets-for-therapeutic-antibodies/
Difficult transmembrane protein targets for therapeutic antibodies - Pharmaceutical Processing World
What is the current landscape of antibodies targeting membrane proteins? As of June 2022, 162 antibodies had been approved for a wide array of diseases in the...
protein targetstherapeutic antibodiespharmaceutical processingdifficultworld
https://www.ddw-online.com/t/therapeutic-antibodies/
Therapeutic Antibodies - Drug Discovery World (DDW)
drug discovery worldtherapeutic antibodiesddw
https://pubmed.ncbi.nlm.nih.gov/38975336/
IMGT/mAb-KG: the knowledge graph for therapeutic monoclonal antibodies - PubMed
In February 2024, IMGT/mAb-KG, encompassing a total of 139,629 triplets, provides access to 1,489 mAbs, approximately 500 targets, and over 500 clinical...
the knowledgemonoclonal antibodiesimgtmabkg
https://www.nasdaq.com/press-release/immunoprecise-antibodies-advances-therapeutic-innovation-groundbreaking-rabbit
ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody...
ImmunoPrecise Antibodies Ltd., ImmunoPrecise Antibodies Ltd., an AI-driven biotherapeutic research and technology company, today proudly announces the clinical...
therapeutic innovationrabbit antibodyantibodiesadvancesgroundbreaking
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1393839/full
Frontiers | IMGT/mAb-KG: the knowledge graph for therapeutic monoclonal antibodies
Apr 9, 2026 - Therapeutic monoclonal antibodies have demonstrated promising outcomes in diverse clinical indications, including but not limited to graft rejection, cancer,...
the knowledgemonoclonal antibodiesfrontiersimgtmab